UAE Breat Cancer Study Finds A Breakthrough in Treatment Method
- Publish date: Monday، 09 August 2021
- Related articles
- 60 UAE hotels to Raise Funds for Al Jalila Foundation for Breast Cance
- UAE: New COVID-19 Procedures Announced for Government Entities
- Express PCR Price in Abu Dhabi Revised
A study conducted by Emirates Cancer Society and Burjeel Hospitals made a breakthrough in the field of breast cancer.
فيديو ذات صلة
This browser does not support the video element.
According to the study, Oncologists found a different genetic mutation compared in Middle Eastern women to those seen in western women with breast cancer. This could affect how they respond to treatment.
The findings of the study conducted on 87 women from across the region over five years (from 2016 to 2021) will help doctors deliver personalised treatment to increase survival rates.
Read More: Pictures: Bollywood's Most Influential Women
Genetic mutations were analysed in women from the UAE, Saudi Arabia, Algeria, Egypt, Iraq, Jordan, Lebanon, Libya, Morocco, Oman, Palestine, Qatar, Sudan, Syria and Tunisia.
If five women come with stage 4 breast cancer, each woman could have a different treatment programme, based on their genes
Prof Humaid Al Shamsi, president of the Emirates Cancer Society, who led the study, said “This research shows the UAE is making strong steps forward in the war on breast cancer,” .
“The symptoms are very similar in all breast cancers, but the treatment can be a paradigm. He added “Some respond better to chemotherapy, while others may require targeted therapy or immunotherapy.
“Understanding genetic mutations enables us to give a more personalised treatment, which is the future of cancer treatment.”